Metaraminol use during spinal anaesthesia for caesarean section

a meta-analysis of randomised controlled trials

E. Chao, H. L. Sun, S. W. Huang, J. H. Liao, P. L. Ma, H. C. Chen

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Introduction: During caesarean section, the use of a vasopressor is often required to achieve haemodynamic stability of the parturient. Metaraminol is a vasopressor used in this context in some countries. However, the differences between metaraminol and other vasopressors remain unclear. Methods: A search of the PubMed, Cochrane Library, and Embase databases was performed to identify randomised controlled trials comparing the use of metaraminol with other vasopressors during spinal anaesthesia at caesarean section. The selected studies were subjected to meta-analysis and risk-of-bias assessment. Results: Four randomised, controlled trials met the selection criteria and 409 parturients who underwent an elective caesarean section were included in this meta-analysis. The quality of these trials was good. Metaraminol was associated with higher umbilical arterial pH (standardised mean difference [SMD] 0.82, 95% CI 0.01 to 1.62, P=0.05); a lower incidence of fetal acidosis (RR 0.08, 95% CI 0.01–0.63, P=0.02); and a lower incidence of nausea or vomiting (RR 0.16, 95% CI 0.04 to 0.57, P=0.0005) than was ephedrine. Metaraminol resulted in higher umbilical arterial pH (SMD 0.42, 95% CI 0.15 to 0.68, P=0.002) but a higher incidence of reactive hypertension (RR 1.80, 95% CI 1.32 to 2.46, P=0.0002) than did phenylephrine. Conclusion: The results of this study showed that for spinal anaesthesia at elective caesarean section, metaraminol may be a more suitable vasopressor than ephedrine and its effects are at least not inferior to those of phenylephrine.

Original languageEnglish
JournalInternational Journal of Obstetric Anesthesia
DOIs
Publication statusPublished - Jan 1 2019

Fingerprint

Metaraminol
Spinal Anesthesia
Cesarean Section
Meta-Analysis
Randomized Controlled Trials
Umbilicus
Ephedrine
Phenylephrine
Incidence
Parturition
Acidosis
PubMed
Nausea
Patient Selection
Libraries
Vomiting
Hemodynamics
Databases
Hypertension

Keywords

  • Caesarean section
  • Ephedrine
  • Meta-analysis
  • Metaraminol
  • Phenylephrine
  • Spinal anaesthesia
  • Systematic review

ASJC Scopus subject areas

  • Obstetrics and Gynaecology
  • Anesthesiology and Pain Medicine

Cite this

@article{278b65ce8dc74a508aa15e999ef8cfd1,
title = "Metaraminol use during spinal anaesthesia for caesarean section: a meta-analysis of randomised controlled trials",
abstract = "Introduction: During caesarean section, the use of a vasopressor is often required to achieve haemodynamic stability of the parturient. Metaraminol is a vasopressor used in this context in some countries. However, the differences between metaraminol and other vasopressors remain unclear. Methods: A search of the PubMed, Cochrane Library, and Embase databases was performed to identify randomised controlled trials comparing the use of metaraminol with other vasopressors during spinal anaesthesia at caesarean section. The selected studies were subjected to meta-analysis and risk-of-bias assessment. Results: Four randomised, controlled trials met the selection criteria and 409 parturients who underwent an elective caesarean section were included in this meta-analysis. The quality of these trials was good. Metaraminol was associated with higher umbilical arterial pH (standardised mean difference [SMD] 0.82, 95{\%} CI 0.01 to 1.62, P=0.05); a lower incidence of fetal acidosis (RR 0.08, 95{\%} CI 0.01–0.63, P=0.02); and a lower incidence of nausea or vomiting (RR 0.16, 95{\%} CI 0.04 to 0.57, P=0.0005) than was ephedrine. Metaraminol resulted in higher umbilical arterial pH (SMD 0.42, 95{\%} CI 0.15 to 0.68, P=0.002) but a higher incidence of reactive hypertension (RR 1.80, 95{\%} CI 1.32 to 2.46, P=0.0002) than did phenylephrine. Conclusion: The results of this study showed that for spinal anaesthesia at elective caesarean section, metaraminol may be a more suitable vasopressor than ephedrine and its effects are at least not inferior to those of phenylephrine.",
keywords = "Caesarean section, Ephedrine, Meta-analysis, Metaraminol, Phenylephrine, Spinal anaesthesia, Systematic review",
author = "E. Chao and Sun, {H. L.} and Huang, {S. W.} and Liao, {J. H.} and Ma, {P. L.} and Chen, {H. C.}",
year = "2019",
month = "1",
day = "1",
doi = "10.1016/j.ijoa.2019.01.009",
language = "English",
journal = "International Journal of Obstetric Anesthesia",
issn = "0959-289X",
publisher = "Churchill Livingstone",

}

TY - JOUR

T1 - Metaraminol use during spinal anaesthesia for caesarean section

T2 - a meta-analysis of randomised controlled trials

AU - Chao, E.

AU - Sun, H. L.

AU - Huang, S. W.

AU - Liao, J. H.

AU - Ma, P. L.

AU - Chen, H. C.

PY - 2019/1/1

Y1 - 2019/1/1

N2 - Introduction: During caesarean section, the use of a vasopressor is often required to achieve haemodynamic stability of the parturient. Metaraminol is a vasopressor used in this context in some countries. However, the differences between metaraminol and other vasopressors remain unclear. Methods: A search of the PubMed, Cochrane Library, and Embase databases was performed to identify randomised controlled trials comparing the use of metaraminol with other vasopressors during spinal anaesthesia at caesarean section. The selected studies were subjected to meta-analysis and risk-of-bias assessment. Results: Four randomised, controlled trials met the selection criteria and 409 parturients who underwent an elective caesarean section were included in this meta-analysis. The quality of these trials was good. Metaraminol was associated with higher umbilical arterial pH (standardised mean difference [SMD] 0.82, 95% CI 0.01 to 1.62, P=0.05); a lower incidence of fetal acidosis (RR 0.08, 95% CI 0.01–0.63, P=0.02); and a lower incidence of nausea or vomiting (RR 0.16, 95% CI 0.04 to 0.57, P=0.0005) than was ephedrine. Metaraminol resulted in higher umbilical arterial pH (SMD 0.42, 95% CI 0.15 to 0.68, P=0.002) but a higher incidence of reactive hypertension (RR 1.80, 95% CI 1.32 to 2.46, P=0.0002) than did phenylephrine. Conclusion: The results of this study showed that for spinal anaesthesia at elective caesarean section, metaraminol may be a more suitable vasopressor than ephedrine and its effects are at least not inferior to those of phenylephrine.

AB - Introduction: During caesarean section, the use of a vasopressor is often required to achieve haemodynamic stability of the parturient. Metaraminol is a vasopressor used in this context in some countries. However, the differences between metaraminol and other vasopressors remain unclear. Methods: A search of the PubMed, Cochrane Library, and Embase databases was performed to identify randomised controlled trials comparing the use of metaraminol with other vasopressors during spinal anaesthesia at caesarean section. The selected studies were subjected to meta-analysis and risk-of-bias assessment. Results: Four randomised, controlled trials met the selection criteria and 409 parturients who underwent an elective caesarean section were included in this meta-analysis. The quality of these trials was good. Metaraminol was associated with higher umbilical arterial pH (standardised mean difference [SMD] 0.82, 95% CI 0.01 to 1.62, P=0.05); a lower incidence of fetal acidosis (RR 0.08, 95% CI 0.01–0.63, P=0.02); and a lower incidence of nausea or vomiting (RR 0.16, 95% CI 0.04 to 0.57, P=0.0005) than was ephedrine. Metaraminol resulted in higher umbilical arterial pH (SMD 0.42, 95% CI 0.15 to 0.68, P=0.002) but a higher incidence of reactive hypertension (RR 1.80, 95% CI 1.32 to 2.46, P=0.0002) than did phenylephrine. Conclusion: The results of this study showed that for spinal anaesthesia at elective caesarean section, metaraminol may be a more suitable vasopressor than ephedrine and its effects are at least not inferior to those of phenylephrine.

KW - Caesarean section

KW - Ephedrine

KW - Meta-analysis

KW - Metaraminol

KW - Phenylephrine

KW - Spinal anaesthesia

KW - Systematic review

UR - http://www.scopus.com/inward/record.url?scp=85061401976&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85061401976&partnerID=8YFLogxK

U2 - 10.1016/j.ijoa.2019.01.009

DO - 10.1016/j.ijoa.2019.01.009

M3 - Article

JO - International Journal of Obstetric Anesthesia

JF - International Journal of Obstetric Anesthesia

SN - 0959-289X

ER -